Searching For Real Value In Market Debris At Avid Bioservices Inc (NASDAQ: CDMO)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, CDMO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Avid Bioservices Inc is $796.98M. A total of 1.29 million shares were traded on the day, compared to an average of 2.12M shares.

In the most recent transaction, Richieri Richard A. sold 2,283 shares of CDMO for 12.37 per share on Jan 10 ’25. After the transaction, the Chief Operations Officer now owns 49,535 company shares. In a previous transaction on Jan 10 ’25, Richieri Richard A. sold 200 shares at 12.37 per share. CDMO shares that Chief Operations Officer owns now total 8,785.

Among the insiders who bought shares, Richard A. Richieri acquired of 2,483 shares on Jan 10 ’25 at a per-share price of $12.37. In another insider transaction, Richieri Richard A. sold 3,843 shares at $12.22 per share on Dec 26 ’24. Company shares held by the Chief Operations Officer now total 44,556.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CDMO has a high of $12.48 and a low of $5.90.

As of this writing, CDMO has an earnings estimate of -$0.04 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.04.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CDMO’s latest balance sheet shows that the firm has $126.17M in Cash & Short Term Investments as of fiscal 2022. There were $182.53M in debt and $75.76M in liabilities at the time. Its Book Value Per Share was $0.70, while its Total Shareholder’s Equity was $174.53M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDMO is Buy with a score of 3.40.

Most Popular

Related Posts